The CERT1 gene gives cells instructions for moving ceramide, a fatty substance your body uses to make important parts of cell membranes. When this gene does not work properly, cells may handle these fats poorly, which can affect brain development and growth. The protein made by this gene helps your cells keep membranes and cell signaling in better balance. Pathogenic variants in the CERT1 gene are linked to a rare condition that can include developmental delay, intellectual disability, low muscle tone, and seizures.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or regulate processes in the body. Some genes contain the directions for making proteins, the parts of cells that do the work. Others mainly control when certain processes take place, where they take place, and how strongly they occur. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic further, you can learn more in the LearnHub.
Overview
CERT1Gene function
What if the gene works
The CERT1 gene helps move a fat molecule called ceramide inside cells. This supports making sphingomyelin, a key fat in cell membranes. It also helps cells keep fat balance for normal growth and signaling.
Risk
What if the gene does not work
Variants in the CERT1 gene most often affect brain development, leading to developmental delay, intellectual disability, speech difficulties, and sometimes seizures or balance problems. Effects can range from milder learning problems to earlier, broader neurodevelopmental challenges.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the CERT1 gene is currently established, so care is supportive and guided by a person's symptoms rather than a targeted drug choice. The CERT1 gene is being studied in early research as a possible drug target in pathways that control ceramide balance, but this has not led to guideline-based treatment for people with a CERT1 variant.
Gene function
What if the gene works
Cells need a steady supply of certain fats to build healthy membranes and keep everyday signaling on track. The CERT1 gene helps move one of these fats, called ceramide, from the cell’s factory area to the place where it is turned into other useful membrane fats. Understanding what the CERT1 gene does in cells helps explain how membranes stay organized and functional.
The CERT1 gene helps your cells carry ceramide, a fatty building block, from one cell compartment to another. This direct handoff gets it to the place where other membrane fats are made.
By delivering ceramide, the CERT1 gene supports production of sphingomyelin, a common fat in cell membranes. This helps cells build outer layers that stay stable and flexible.
This gene helps keep ceramide and related membrane fats balanced in different parts of the cell. That balance supports routine signaling and orderly membrane structure.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CERT1 gene can change how the CERT protein is folded or how tightly it is switched off, altering ceramide transport between cell compartments. Some changes are milder and only partly disturb transport, while more disruptive variants can make the protein overactive or less stable. This is how CERT1 gene variants affect protein function. In neurodevelopmental conditions caused by pathogenic variants in the CERT1 gene, larger functional changes often link to earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the CERT1 gene cause CerTra syndrome, a rare neurodevelopmental condition. In reports describing how CERT1 gene variants are linked to conditions, the clearest and most established link is to developmental delay or intellectual disability, often with low muscle tone, seizures, or movement differences. Some people also have growth concerns, feeding difficulties, or autism features, but the pattern can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct impact on health and instead represent natural human variation. For many genes, carrying a variant connected with a condition indicates a possible association rather than a confirmed diagnosis, especially when several genes and environmental factors play a role. In some instances, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to CERT1. Anyone with concerns about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of CERT1 variants
For families trying to understand how CERT1 gene variants are inherited, the well-established pattern for CERT1-related conditions is autosomal dominant. This means a person only needs one disease-causing variant in the CERT1 gene to have the condition, and an affected parent can pass it to each child with a 50% chance in every pregnancy. Some people have a new (de novo) variant in the CERT1 gene, which means it started in them and was not inherited from either parent.
What does my CERT1 result mean for my family?
A harmful change in the CERT1 gene is linked to a condition that usually follows a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. For many families, this means relatives may wish to talk with their care team about whether testing would be useful. Some CERT1 changes happen new in the affected child, so a parent may not have the variant.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CERT1 variants uses a blood or saliva sample to read the CERT1 gene and look for spelling changes in its DNA. CERT1 genetic testing may be done as part of a multigene panel or full exome sequencing, and results help show whether a detected variant is likely benign or linked to disease.
When should I consider getting a genetic test?
Genetic testing may be worth considering if a child has unexplained developmental delay, seizures, low muscle tone, or movement and behavior differences. Finding a change in the CERT1 gene can help confirm the cause and give families clearer information about future pregnancies.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it clarifies varies by the condition and the specific type of variant. Over time, how the body works is also shaped by factors such as lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, do less for another, or cause more side effects in someone else. Part of the difference comes from inherited changes that influence how the body breaks down, moves, or responds to a medication. These differences are common and can shape both how well a treatment works and how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This understanding can support more informed and personalized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CERT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so speak with your doctor if you have side effects, new symptoms, or concerns about how a medicine is working.
History
Researchers identified the protein made by the CERT1 gene in the early 2000s while studying how fats move inside cells. It was first described as a ceramide transport protein, and this helped open a new chapter in lipid biology. Building on this early work, scientists linked the gene to a broader network that controls cell membranes and signaling. The gene was also known for a time by another name, COL4A3BP, before CERT1 became the clearer label in many genetics settings. In the 2010s, rare CERT1 variants were connected to a neurodevelopmental condition, which brought the gene into clinical genetics as well as basic research. Over time, descriptions became more precise as lab studies and patient findings were brought together.